Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02017379 · ClinicalTrials.gov registry record · NA

Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.

A NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT02017379: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.

NCT02017379 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02017379, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to patients who will not receive either of these medications before their endoscopy.

Primary Outcome

Whether erythromycin, metoclopramide versus control can enable visualization of the entire gastric mucosa .

Interventions

  • DRUG Erythromycin
  • DRUG Metoclopromide

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2014-06
Est. Completion 2014-09
Phase NA

Why NCT02017379 stopped before completion

NCT02017379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Erythromycin is the first listed.

NCT02017379 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02017379 about?

NCT02017379 is a clinical study titled "Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.". This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to...

What is the current status of trial NCT02017379?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-06. Estimated completion is 2014-09.

What interventions are being tested in trial NCT02017379?

The interventions under investigation include: Erythromycin (DRUG), Metoclopromide (DRUG).

Who is sponsoring clinical trial NCT02017379?

This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02017379's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02017379, the US trial registry maintained by the National Library of Medicine. NCT02017379 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.